Perrigo Company PLC marks another first in its transition to being entirely consumer health-focused with approval in the US of proton pump inhibitor omeprazole magnesium 20-mg delayed-released in mini-capsule format.
The capsule is 70% smaller than tablets of omeprazole currently available in the Prilosec OTC brand marketed by Procter...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?